Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Hohmann

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 1999
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout miceA Zimmer, A M Zimmer, A G Hohmann, et al.
British Journal of Pharmacology|December 13, 2006
Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysisT Gutierrez, J N Farthing, A M Zvonok, et al.
Science (New York, N.Y.)|August 1, 2000
Altered nociceptive neuronal circuits after neonatal peripheral inflammationM A Ruda, Q D Ling, A G Hohmann, et al.
Brain Research|December 5, 1998
Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivityN M Strangman, S L Patrick, A G Hohmann, et al.
Brain Research|September 23, 2003
Effects of neurotoxic destruction of descending noradrenergic pathways on cannabinoid antinociception in models of acute and tonic nociceptionT Gutierrez, A G Nackley, M H Neely, et al.
Neuroscience|April 17, 2010
Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult ratsN R Sciolino, M Bortolato, S A Eisenstein, et al.
Life Sciences|August 26, 1999
The neurobiology of cannabinoid analgesiaJ M Walker, A G Hohmann, W J Martin, et al.
Neuroscience|February 1, 1996
Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonistK Tsou, K A Lowitz, A G Hohmann, et al.
Brain Research|May 22, 1992
Autoradiographic distribution of [3H](+)-pentazocine and [3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative studyJ M Walker, W D Bowen, S R Goldstein, et al.
Brain Research|October 26, 1992
Effects of 1,3-di-o-tolylguanidine (DTG), a sigma ligand, on local cerebral glucose utilization in rat brainA G Hohmann, R R Matsumoto, M K Hemstreet, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Proceedings of the National Academy of Sciences of the United States of America|May 13, 1999
Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout miceA Zimmer, A M Zimmer, A G Hohmann, et al.
British Journal of Pharmacology|December 13, 2006
Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysisT Gutierrez, J N Farthing, A M Zvonok, et al.
Science (New York, N.Y.)|August 1, 2000
Altered nociceptive neuronal circuits after neonatal peripheral inflammationM A Ruda, Q D Ling, A G Hohmann, et al.
Brain Research|December 5, 1998
Evidence for a role of endogenous cannabinoids in the modulation of acute and tonic pain sensitivityN M Strangman, S L Patrick, A G Hohmann, et al.
Brain Research|September 23, 2003
Effects of neurotoxic destruction of descending noradrenergic pathways on cannabinoid antinociception in models of acute and tonic nociceptionT Gutierrez, A G Nackley, M H Neely, et al.
Neuroscience|April 17, 2010
Social isolation and chronic handling alter endocannabinoid signaling and behavioral reactivity to context in adult ratsN R Sciolino, M Bortolato, S A Eisenstein, et al.
Life Sciences|August 26, 1999
The neurobiology of cannabinoid analgesiaJ M Walker, A G Hohmann, W J Martin, et al.
Neuroscience|February 1, 1996
Suppression of noxious stimulus-evoked expression of Fos protein-like immunoreactivity in rat spinal cord by a selective cannabinoid agonistK Tsou, K A Lowitz, A G Hohmann, et al.
Brain Research|May 22, 1992
Autoradiographic distribution of [3H](+)-pentazocine and [3H]1,3-di-o-tolylguanidine (DTG) binding sites in guinea pig brain: a comparative studyJ M Walker, W D Bowen, S R Goldstein, et al.
Brain Research|October 26, 1992
Effects of 1,3-di-o-tolylguanidine (DTG), a sigma ligand, on local cerebral glucose utilization in rat brainA G Hohmann, R R Matsumoto, M K Hemstreet, et al.
Pageof 3